Rufinamide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Rufinamide and local guidelines before prescribing.
Anticonvulsant
Mechanism
Sodium-channel modulator.
Uses
Lennox-Gastaut syndrome.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Somnolence, headache, QT shortening, vomiting.
Interactions
Valproate raises levels.
Contraindications and cautions
Familial short QT syndrome
Monitoring
ECG
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Caution in hepatic impairment
Overdose and reversal
Supportive
Special advice
Shortens QT so avoid in familial short QT.
More from the textbook: uses, cautions and other points
- Tonic or atonic | Valproate (males), lamotrigine; specialist options (rufinamide, cannabidiol)
Neurology: Epilepsy - Lennox–Gastaut syndrome | Onset 1–8 years; multiple seizure types (tonic, atonic "drop attacks", atypical absences); learning disability; EEG - slow spike and wave. Hard to treat - valproate, lamotrigine, rufinamide, cannabidiol, ketogenic diet.
Paediatrics: Neurology, bones and joints in children
Where it is discussed in the book
- Neurology: Epilepsy (1 mention)
- Paediatrics: Neurology, bones and joints in children (1 mention)
- Integrated paediatrics chapter (1 mention)